Loading…
Administrative False Claims Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
88pct
102d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Administrative False Claims Act of 2021 This bill modifies provisions regarding fraud committed against the federal government. Specifically, the bill raises the maximum amount of a fraud claim that may be handled administratively from $150,000 to $1 million, allows responsibilities in the administrative process assigned to the Attorney General or an Assistant Attorney General to be delegated to other Department of Justice employees, and allows the government to recoup costs for investigating and prosecuting these frauds.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 162.
Committee on the Judiciary. Reported by Senator Durbin with amendments. Without written report.
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Government Issues
S.2428 False Claims Amendments Act of 2021 S.2429 Administrative False Claims Act of 2021 S.4522 A bill to enhance rulemaking requirements for the Bureau of Consumer Financial Protection
Client expense: $570,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Government Issues
H.R. 1/S. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 2617, Consolidated Appropriations Act, 2023, including provisions related to Senate Amendment 6597 H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 H.R. 3843, Merger Filing Fee Modernization Act of 2022 H.R. 4737, Foreign Extortion Prevention Act H.R. 4773, Consumer Financial Protection Commission Act H.R. 5773/S. 2079, Stop Settlement Slush Funds Act of 2021 H.R. 6843, Building Civic Bridges Act S. 742, Open and Responsive Government Act of 2021 S. 2428, False Claims Amendments Act of 2021 S. 2429, Administrative False Claims Act of 2021 S. 3137, Foreign Extortion Prevention Act S. 4822, Democracy Is Strengthened by Casting Light On Spending in Elections (DISCLOSE) Act of 2022 Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Nomination of Robert Gordon to be Assistant Secretary for Financial Resources at the Department of Health and Human Services Nomination of John Goffman to serve as Associate Administrator for the Office of Air and Radiation (OAR) at the U.S. Environmental Protection Agency (EPA) Nomination of Richard Revesz to be OIRA Administrator Nomination of Shailen Bhatt to be Administrator of the Federal Highway Administration (FHWA) Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; COVID-19 vaccine requirements for federal contractors; False Claims Act and potential amendments related to materiality, and disclosure of third-party funding (31 U.S.C. 3729 - 3733); Legal Services Corporation; class action reform; antitrust; Corporate Enforcement Policy Issues Memorandum from the Deputy Attorney General, dated October 31, 2021; memorandum from the Deputy Attorney General dated September 15, 2022, and issues related to private devices, third party messaging applications, and compliance with foreign law; potential legislation dealing with state attorney general use of state AG use of outside contingency fee counsel; trial lawyer advertising and pharmaceutical litigation; unfair or deceptive advertising related to lawsuits; potential legislation on judicial review of administrative agency activities; Department of Justice corporate enforcement policy; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; implementation of the American Rescue Plan Act (P.L. 117-2); decisions of the Congressional Parliamentarians; reopening of Capitol Hill to visitors and the public; urging a rapid nomination of a new FAA Administrator; defense industrial base;
Client expense: $20,990,000 · Firm income: Not reported
2022 · fourth_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: Not reported · Firm income: $42,000
2022 · fourth_quarter · Government Issues
S.2429, Administrative False Claims Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: $1,420,000 · Firm income: Not reported
| Democratic |
| NH |
| Patrick J. Leahy | Democratic | VT |
| Richard Blumenthal | Democratic | CT |
| Richard J. Durbin | Democratic | IL |
| Rick Scott | Republican | FL |
| Rob Portman | Republican | OH |
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Monitored S. 2429, Administrative False Claims Act
Client expense: Not reported · Firm income: $50,000
2022 · fourth_quarter · Housing
Issues under the jurisdiction of the U.S. House Appropriations Subcommittee on Financial Services and General Government; Issues under the jurisdiction of the U.S. House Appropriations Subcommittee on Transportation and Housing and Urban Development; General FHA, FHFA, VA issues; Oversight of federal housing policy; General diversity and inclusion issues; General digital mortgage issues; Tax foreclosure prevention; FHA technology funding; Issues around forbearance and loss mitigation; H.R. 2553 - Real Estate Valuation Fairness and Improvement Act of 2021; S. 2429, Adminstrative False Claims Act; H.R. 7022, Strengthening Cybersecurity for the Financial Sector Act of 2022; H.R. 7735 and S. 4208, Improving Access to the VA Home Loan Benefit Act of 2022
Client expense: $430,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2022 · fourth_quarter · Government Issues
Issues related to fraud in government contracting and SEC/CFTC rewards programs, S2428 and S2429; HR 7195
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
2022 · fourth_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
S. 2428: False Claims Amendments Act of 2021 S. 2429: Administrative False Claims Act of 2021 S. 4546: Time to Choose Act of 2022 S. 4516: Combating Obstructive National Security Underreporting of Legitimate Threats (CONSULT) Act of 2022
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
S.2428 False Claims Amendments Act of 2021 S.2429 Administrative False Claims Act of 2021 S.4522 A bill to enhance rulemaking requirements for the Bureau of Consumer Financial Protection HR 4350 The National Defense Authorization Act for Fiscal Year 2022
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: $1,380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
H.R. 1/S. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 H.R. 3843, Merger Filing Fee Modernization Act of 2022 H.R. 4737, Foreign Extortion Prevention Act H.R. 4773, Consumer Financial Protection Commission Act H.R. 5773/S. 2079, Stop Settlement Slush Funds Act of 2021 H.R. 6843, Building Civic Bridges Act H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 S. 742, Open and Responsive Government Act of 2021 S. 2428, False Claims Amendments Act of 2021 S. 2429, Administrative False Claims Act of 2021 S. 3137, Foreign Extortion Prevention Act S. 4822, Democracy Is Strengthened by Casting Light On Spending in Elections (DISCLOSE) Act of 2022 Nomination of Grant Harris to be Assistant Secretary of Commerce for Industry and Analysis at the United States Department of Commerce Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Nomination of Laurie Locascio to be Under Secretary of Commerce for Standards and Technology Nominations of Bradley Merrill Thompson, Beena Ammanath, Christina Montgomery, Paul Daugherty, and Dr. Swani Sivasubramanian to serve on the National Artificial Intelligence Advisory Committee (NAIAC) Nomination of Robert Gordon to be Assistant Secretary for Financial Resources at the Department of Health and Human Services Nomination of John Goffman to serve as Associate Administrator for the Office of Air and Radiation (OAR) at the U.S. Environmental Protection Agency (EPA) Nomination of Richard Revesz to be OIRA Administrator Nomination of Shailen Bhatt to be Administrator of the Federal Highway Administration (FHWA) Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; COVID-19 vaccine requirements for federal contractors; False Claims Act and potential amendments related to materiality, and disclosure of third-party funding, U.S. Code cite. 31 USC 3729, et seq.; class action reform; antitrust; Corporate Enforcement Policy Issues Memorandum from the Deputy Attorney General, dated October 31, 2021; potential legislation dealing with state attorney general use of state AG use of outside contingency fee counsel; unfair or deceptive advertising related to lawsuits; potential legislation on judicial review of administrative agency activities; rescinding by the Department of Justice the interim final rule relating to Guidelines and Limitations for Settlement Agreements Involving Payments to Non-Governmental Third Parties; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; implementation of the American Rescue Plan Act (P.L. 117-2); decisions of the Congressional Parliamentarians; reopening of Capitol Hill to visitors and the public; urging a rapid nomination of a new FAA Administrator; supply chain and the defense industrial base; small business innovation research; Buy America provisions especially in infrastructure legislation; defense industrial base;
Client expense: $23,940,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Security Council (NSC), SENATE, State, Dept of (DOS)
2022 · third_quarter · Housing
Issues under the jurisdiction of the U.S. House Appropriations Subcommittee on Financial Services and General Government; Issues under the jurisdiction of the U.S. House Appropriations Subcommittee on Transportation and Housing and Urban Development; General FHA, FHFA, VA issues; Oversight of federal housing policy; General diversity and inclusion issues; General digital mortgage issues; Tax foreclosure prevention; FHA technology funding; Issues around forbearance and loss mitigation; H.R. 2553 - Real Estate Valuation Fairness and Improvement Act of 2021; S. 2429, Adminstrative False Claims Act; H.R. 7022, Strengthening Cybersecurity for the Financial Sector Act of 2022; H.R. 7735 and S. 4208, Improving Access to the VA Home Loan Benefit Act of 2022
Client expense: $530,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2022 · third_quarter · Government Issues
Issues related to fraud in government contracting and SEC/CFTC rewards programs, S2428 and S2429; HR 7195
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Law Enforcement/Crime/Criminal Justice
Discussions related to S. 2429, Administrative False Claims Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2022 · third_quarter · Government Issues
S.2429, Administrative False Claims Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Torts
Litigation reform measures generally Issues relating to nondisclosure agreements USERRA Issues - Uniformed Services Employment and Reemployment Rights Act H.R. 963, FAIR Act H.R. 2025/S. 840, Litigation Funding Transparency Act of 2021 H.R. 3460, State Antitrust Enforcement Venue Act of 2021 S. 2428, False Claims Amendments Act of 2021 S. 2429, Administrative False Claims Act of 2021 H.R. 4445, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 H.R. 7701, Wage Theft Prevention and Wage Recovery Act H.R. 8227, Speak Out Act S. 4524, Speak Out Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S. 2428: False Claims Amendments Act of 2021 S. 2429: Administrative False Claims Act of 2021 S. 4546: Time to Choose Act of 2022 S. 4516: Combating Obstructive National Security Underreporting of Legitimate Threats (CONSULT) Act of 2022 Introduced (and draft) legislation regarding services firms in Russia, including H.R. 7185 (Federal Contracting for Peace and Security Act)
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $20,000
Government targets: SENATE
2022 · third_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $20,000
Government targets: SENATE
2022 · second_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: $1,620,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Government Issues
H.R. 1/S. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 H.R. 4737, Foreign Extortion Prevention Act H.R. 4773, Consumer Financial Protection Commission Act H.R. 5773/S. 2079, Stop Settlement Slush Funds Act of 2021 H.R. 6843, Building Civic Bridges Act H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 S. 742, Open and Responsive Government Act of 2021 S. 2428, False Claims Amendments Act of 2021 S. 2429, Administrative False Claims Act of 2021 Draft legislation titled Department of State, Foreign Operation and Related Programs Appropriations Act, 2023 Nomination of Grant Harris to be Assistant Secretary of Commerce for Industry and Analysis at the United States Department of Commerce Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Nomination of Laurie Locascio to be Under Secretary of Commerce for Standards and Technology Nominations of Bradley Merrill Thompson, Beena Ammanath, Christina Montgomery, Paul Daugherty, and Dr. Swani Sivasubramanian to serve on the National Artificial Initiative Advisory Committee (NAIAC) Nomination of Gigi Sohn to be a Commissioner on the Federal Communications Commission Nomination of Kathryn Huff to be an Assistant Secretary of Energy Nomination of Alice Hill to serve as the Deputy Administrator for Resilience at the Federal Emergency Management Agency Nomination of Robert Gordon to be Assistant Secretary for Financial Resources at the Department of Health and Human Services Nomination of Alvaro Bedoya to be a Member of the Federal Trade Commission Nomination of Katherine Vidal to be Director of the U.S. Patent and Trademark Office (USPTO) Nomination of Mark Uyeda to be Commissioner of the U.S. Securities and Exchange Commission (SEC) Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; COVID-19 vaccine requirements for federal contractors; False Claims Act and potential amendments related to materiality, and disclosure of third-party funding, U.S. Code cite. 31 USC 3729, et seq.; class action reform; antitrust; Corporate Enforcement Policy Issues Memorandum from the Deputy Attorney General, dated October 31, 2021; potential legislation dealing with state attorney general use of state AG use of outside contingency fee counsel; potential legislation on judicial review of administrative agency activities; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; implementation of the American Rescue Plan Act (P.L. 117-2); decisions of the Congressional Parliamentarians; reopening of Capitol Hill to visitors and the public; urging a rapid nomination of a new FAA Administrator; supply chain and the defense industrial base; small business innovation research; Buy America provisions especially in infrastructure legislation;
Client expense: $15,800,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, State, Dept of (DOS)
2022 · second_quarter · Housing
Issues under the jurisdiction of the U.S. House Appropriations Subcommittee on Financial Services and General Government; Issues under the jurisdiction of the U.S. House Appropriations Subcommittee on Transportation and Housing and Urban Development; General FHA, FHFA, VA issues; Oversight of federal housing policy; General diversity and inclusion issues; General digital mortgage issues; Tax foreclosure prevention; FHA technology funding; Issues around forbearance and loss mitigation; H.R.2553 - Real Estate Valuation Fairness and Improvement Act of 2021; S. 2429, Adminstrative False Claims Act; H.R.7022, Strengthening Cybersecurity for the Financial Sector Act of 2022
Client expense: $460,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2022 · second_quarter · Government Issues
S.2429, Administrative False Claims Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Law Enforcement/Crime/Criminal Justice
Discussions related to S. 2429, Administrative False Claims Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2022 · second_quarter · Torts
Litigation reform measures generally Issues relating to nondisclosure agreements USERRA Issues - Uniformed Services Employment and Reemployment Rights Act H.R. 963, FAIR Act H.R. 2025/S. 840, Litigation Funding Transparency Act of 2021 H.R. 3460, State Antitrust Enforcement Venue Act of 2021 S.2428, False Claims Amendments Act of 2021 S.2429, Administrative False Claims Act of 2021 H.R.4445, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 H.R. 7701 Wage, Theft Prevention and Wage Recovery Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · first_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · second_quarter · Government Issues
Issues related to fraud in government contracting and SEC/CFTC rewards programs, S2428 and S2429
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $7,792
Government targets: SENATE
2022 · first_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $7,792
Government targets: SENATE
2022 · second_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
2022 · second_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
2022 · second_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
2022 · second_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
2022 · first_quarter · Banking
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $7,792
Government targets: SENATE
2022 · first_quarter · Government Issues
S.2428, False Claims Amendments Act of 2021 as it relates to mortgage banking S.2429, Administrative False Claims Act of 2021 as it relates to mortgage banking
Client expense: Not reported · Firm income: $7,792
Government targets: SENATE
2022 · second_quarter · Housing
1.Nomination of Julia Gordon for FHA Commissioner 2.Nomination of Sandra Thompson for FHFA Director 3.FHFA OIG report on supervision 4.GSE Equity Plans 5.HR 7022, Strengthening Cybersecurity for the Financial Sector Act of 2022 6.P.L. 116-136, CARES Act - implementation issues related to mortgage forbearance and servicer liquidity 7.Issues related to mortgage servicer implementation of borrower forbearance and other borrower assistance under the CARES Act and The American Rescue Plan (Homeowner Assistance Fund). 8.Issues related to appraisal regulation and down payment assistance 9.HR 5376, Build Back Better Act 10.S. 2428 - False Claims Amendments Act of 2021 11.S 2429 - Administrative False Claims Act of 2021 12.HR 2543, Federal Reserve Racial & Economic Equity Act 13.HR 7049, Mortgage Borrower Protection Act of 2022 14.S 1625, HR 3962 Securing and Enabling Commerce Using Remote and Electronic Notarization Act of 2021 15.HR 2553, Real Estate Valuation Fairness and Improvement Act of 2021 16.HR 4495, Downpayment Toward Equity Act of 2021
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Financial Institutions/Investments/Securities
1.Nomination of Julia Gordon for FHA Commissioner 2.Nomination of Sandra Thompson for FHFA Director 3.FHFA OIG report on supervision 4.GSE Equity Plans 5.HR 7022, Strengthening Cybersecurity for the Financial Sector Act of 2022 6.P.L. 116-136, CARES Act - implementation issues related to mortgage forbearance and servicer liquidity 7.Issues related to mortgage servicer implementation of borrower forbearance and other borrower assistance under the CARES Act and The American Rescue Plan (Homeowner Assistance Fund). 8.Issues related to appraisal regulation and down payment assistance 9.HR 5376, Build Back Better Act 10.S. 2428 - False Claims Amendments Act of 2021 11.S 2429 - Administrative False Claims Act of 2021 12.HR 2543, Federal Reserve Racial & Economic Equity Act 13.HR 7049, Mortgage Borrower Protection Act of 2022 14.S 1625, HR 3962 Securing and Enabling Commerce Using Remote and Electronic Notarization Act of 2021 15.HR 2553, Real Estate Valuation Fairness and Improvement Act of 2021 16.HR 4495, Downpayment Toward Equity Act of 2021
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Banking
1.Nomination of Julia Gordon for FHA Commissioner 2.Nomination of Sandra Thompson for FHFA Director 3.FHFA OIG report on supervision 4.GSE Equity Plans 5.HR 7022, Strengthening Cybersecurity for the Financial Sector Act of 2022 6.P.L. 116-136, CARES Act - implementation issues related to mortgage forbearance and servicer liquidity 7.Issues related to mortgage servicer implementation of borrower forbearance and other borrower assistance under the CARES Act and The American Rescue Plan (Homeowner Assistance Fund). 8.Issues related to appraisal regulation and down payment assistance 9.HR 5376, Build Back Better Act 10.S. 2428 - False Claims Amendments Act of 2021 11.S 2429 - Administrative False Claims Act of 2021 12.HR 2543, Federal Reserve Racial & Economic Equity Act 13.HR 7049, Mortgage Borrower Protection Act of 2022 14.S 1625, HR 3962 Securing and Enabling Commerce Using Remote and Electronic Notarization Act of 2021 15.HR 2553, Real Estate Valuation Fairness and Improvement Act of 2021 16.HR 4495, Downpayment Toward Equity Act of 2021
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S. 2428: False Claims Amendments Act of 2021 S. 2429: Administrative False Claims Act of 2021
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
H.R. 349: Coronavirus Vaccine and Therapeutic Development Act of 2021 - Provisions related to manufacturing of COVID-19 treatments and vaccines H.R. 550: Immunization Infrastructure Modernization Act (IIS harmonization) H.R. 724: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 - Provisions related to FDA drug approval process H.R. 832: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation H.R. 1400: COVID-19 Health Disparities Action Act of 2021 - Provisions related to COVID-19 vaccines H.R. 1730: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research H.R. 1873: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products H.R. 2181: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation H.R. 2565: FDA Modernization Act of 2021 - Provisions related to FDA policy and health research H.R. 2815: BIOSIM Act - Provisions related to biosimilars and prescription drug pricing H.R. 2831: Prompt Approval of Safe Generic Drugs Act- Provisions related to FDA policy and approvals H.R. 2869: Increasing Access to Biosimilars Act of 2021 - Provisions related to biosimilars and prescription drug pricing H.R. 2883: Stop Stalling Access to Affordable Medications - Provisions related to citizen petitions H.R. 3656/S. 3087: Vaccine Access Improvement Act (VICP program changes) H.R. 3761: Promising Pathways Act - Provisions related to FDA policy H.R. 3932: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues H.R. 4127: DISARM Act Provisions related to antimicrobial drug development H.R. 4390: PROTECT 340B Act of 2021 - Provisions related to 340B drug discount program H.R. 4472: BENEFIT Act of 2021 - Provisions related to FDA policy H.R. 4511: FDA Advancing Collection of Transformative Science Act or the FACTS Act H.R. 5030: DIVERSE Trials Act - Provisions related to clinical trial diversity H.R. 5416: Give Kids a Chance Act H.R. 5585: Advanced Research Project Agency-Health Act - Provisions related to health research H.R. 5801: HELP Copays Act - Provisions related to prescription drug pricing and cost-sharing H.R. 6000: Cures 2.0 Act - Provisions related to health research H.R. 6228: Capping Prescription Costs Act of 2021 - Provisions related to prescription drug pricing and cost-sharing H.R. 6584: DEPICT Act - To direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes H.R. 6888: Helping Experts Accelerate Rare Treatments Act of 2022 H.R. 6963: Accelerated Approval Integrity Act of 2022 - Provisions related to accelerated approval H.R. 6972: Give Kids a Chance Act of 2022 - Provisions related to additional authorities and pediatric investigations H.R. 6973: Enhanced Access to Affordable Medicines Act of 2022 - Provisions related to labeling H.R. 6988: Drug Manufacturing Innovation Act of 2022 H.R. 6996: Accelerating Access for Patients Act of 2022 H.R. 7006: Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Act H.R. 7008: Pre-Approval Information Exchange Act of 2022 H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 H.R. 7035: Biologics Market Transparency Act of 2022 H.R. 7047: Lowering Costs by Improving Biosimilar Uptake Act S. 154: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021- Provisions related to FDA drug approval process S. 164: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products S. 259: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation S. 562: Ensuring Timely Access to Generics Act of 2021 - Provisions related to citizen petitions S. 670: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research S. 773: A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. - Provisions related to 340B drug discount program S. 912/H.R. 1978: Protecting Seniors Through Immunization Act S. 920: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation S. 1425: Stop STALLING Act - Provisions related to citizen petitions S. 1427: Increasing Access to Biosimilars Act of 2021 - Provisions related to biosimilars and prescription drug pricing S. 1462: Simplifying the Generic Drug Application Process Act - Provisions related to FDA policy and approvals S. 1463: Modernizing Therapeutic Equivalence Rating Determination Act S. 1644: Promising Pathway Act - Provisions related to FDA policy S. 1645: ADAPT Act - Provisions related to FDA policy S. 2076: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 2428: False Claims Amendments Act of 2021 - Provisions related to False Claims Act S. 2429: Administrative False Claims Act of 2021 - Provisions related to False Claims Act S. 2706: DIVERSE Trials Act - Provisions related to FDA policy S. 2837: 340B Accountability Act of 2021 - Provisions related to 340B drug discount program S. 2983: ADAPT for COVID Act - Provisions related to FDA accelerated approval pathways S. 3291: STAAR Act - Provisions related to health research and antibiotic resistance S. 3449: Registration of Certain Foreign Establishments Act S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act Cancer Moonshot Initiative 21st Century Cures 2.0 RFI for Advanced Research Projects Agency - Health (ARPA-H) Department of Homeland Security cybersecurity policy issues Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Drug counterfeiting policy issues PDUFA reauthorization BsUFA reauthorization Competition policy issues Orphan Drug Act (ODA) policy issues Health Advanced Research Projects Agency (HARPA) proposal Expanded access policy issues Antimicrobial resistance (AMR) policy issues High deductible health plans/HSA policy issues Supply chain and foreign manufacturing policy issues Real world evidence policy issues Clinical trial diversity policy issues FDA modernization policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Regulatory efficiencies policy issues COVID-19 policy issues/Emergency supplemental funding Pandemic preparedness policy issues Defense Production Act (DPA) policy issues Final Rule; Importation of Prescription Drugs Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients Nomination of Robert Califf to FDA Commissioner HSA/FSA for Dietary Supplements Dietary Supplement Health and Education Act Reform
Client expense: $1,100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2022 · first_quarter · Torts
S. 840 Third Party Litigation Funding S. 2428 False Claims Act Procedure Modification S. 2429 Civil Remedies H.R. 963 Arbitration Amendment H.R. 2025 Third Party Litigation Funding Oversight S. 3755 Arbitration Reform
Client expense: $1,370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
H.R. 349: Coronavirus Vaccine and Therapeutic Development Act of 2021 - Provisions related to manufacturing of COVID-19 treatments and vaccines H.R. 550: Immunization Infrastructure Modernization Act (IIS harmonization) H.R. 724: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 - Provisions related to FDA drug approval process H.R. 832: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation H.R. 1400: COVID-19 Health Disparities Action Act of 2021 - Provisions related to COVID-19 vaccines H.R. 1730: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research H.R. 1873: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products H.R. 2181: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation H.R. 2565: FDA Modernization Act of 2021 - Provisions related to FDA policy and health research H.R. 2815: BIOSIM Act - Provisions related to biosimilars and prescription drug pricing H.R. 2831: Prompt Approval of Safe Generic Drugs Act- Provisions related to FDA policy and approvals H.R. 2869: Increasing Access to Biosimilars Act of 2021 - Provisions related to biosimilars and prescription drug pricing H.R. 2883: Stop Stalling Access to Affordable Medications - Provisions related to citizen petitions H.R. 3656/S. 3087: Vaccine Access Improvement Act (VICP program changes) H.R. 3761: Promising Pathways Act - Provisions related to FDA policy H.R. 3932: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues H.R. 4127: DISARM Act Provisions related to antimicrobial drug development H.R. 4390: PROTECT 340B Act of 2021 - Provisions related to 340B drug discount program H.R. 4472: BENEFIT Act of 2021 - Provisions related to FDA policy H.R. 4511: FDA Advancing Collection of Transformative Science Act or the FACTS Act H.R. 5030: DIVERSE Trials Act - Provisions related to clinical trial diversity H.R. 5416: Give Kids a Chance Act H.R. 5585: Advanced Research Project Agency-Health Act - Provisions related to health research H.R. 5801: HELP Copays Act - Provisions related to prescription drug pricing and cost-sharing H.R. 6000: Cures 2.0 Act - Provisions related to health research H.R. 6228: Capping Prescription Costs Act of 2021 - Provisions related to prescription drug pricing and cost-sharing H.R. 6584: DEPICT Act - To direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes H.R. 6888: Helping Experts Accelerate Rare Treatments Act of 2022 H.R. 6963: Accelerated Approval Integrity Act of 2022 - Provisions related to accelerated approval H.R. 6972: Give Kids a Chance Act of 2022 - Provisions related to additional authorities and pediatric investigations H.R. 6973: Enhanced Access to Affordable Medicines Act of 2022 - Provisions related to labeling H.R. 6988: Drug Manufacturing Innovation Act of 2022 H.R. 6996: Accelerating Access for Patients Act of 2022 H.R. 7006: Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Act H.R. 7008: Pre-Approval Information Exchange Act of 2022 H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 H.R. 7035: Biologics Market Transparency Act of 2022 H.R. 7047: Lowering Costs by Improving Biosimilar Uptake Act S. 154: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021- Provisions related to FDA drug approval process S. 164: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products S. 259: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation S. 562: Ensuring Timely Access to Generics Act of 2021 - Provisions related to citizen petitions S. 670: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research S. 773: A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. - Provisions related to 340B drug discount program S. 912/H.R. 1978: Protecting Seniors Through Immunization Act S. 920: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation S. 1425: Stop STALLING Act - Provisions related to citizen petitions S. 1427: Increasing Access to Biosimilars Act of 2021 - Provisions related to biosimilars and prescription drug pricing S. 1462: Simplifying the Generic Drug Application Process Act - Provisions related to FDA policy and approvals S. 1463: Modernizing Therapeutic Equivalence Rating Determination Act S. 1644: Promising Pathway Act - Provisions related to FDA policy S. 1645: ADAPT Act - Provisions related to FDA policy S. 2076: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 2428: False Claims Amendments Act of 2021 - Provisions related to False Claims Act S. 2429: Administrative False Claims Act of 2021 - Provisions related to False Claims Act S. 2706: DIVERSE Trials Act - Provisions related to FDA policy S. 2837: 340B Accountability Act of 2021 - Provisions related to 340B drug discount program S. 2983: ADAPT for COVID Act - Provisions related to FDA accelerated approval pathways S. 3291: STAAR Act - Provisions related to health research and antibiotic resistance S. 3449: Registration of Certain Foreign Establishments Act S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act Cancer Moonshot Initiative 21st Century Cures 2.0 RFI for Advanced Research Projects Agency - Health (ARPA-H) Department of Homeland Security cybersecurity policy issues Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Drug counterfeiting policy issues PDUFA reauthorization BsUFA reauthorization Competition policy issues Orphan Drug Act (ODA) policy issues Health Advanced Research Projects Agency (HARPA) proposal Expanded access policy issues Antimicrobial resistance (AMR) policy issues High deductible health plans/HSA policy issues Supply chain and foreign manufacturing policy issues Real world evidence policy issues Clinical trial diversity policy issues FDA modernization policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Regulatory efficiencies policy issues COVID-19 policy issues/Emergency supplemental funding Pandemic preparedness policy issues Defense Production Act (DPA) policy issues Final Rule; Importation of Prescription Drugs Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients Nomination of Robert Califf to FDA Commissioner HSA/FSA for Dietary Supplements Dietary Supplement Health and Education Act Reform
Client expense: $830,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2022 · first_quarter · Torts
Litigation reform measures generally Issues relating to nondisclosure agreements USERRA Issues - Uniformed Services Employment and Reemployment Rights Act H.R. 963 FAIR Act H.R. 2025/S. 840 Litigation Funding Transparency Act of 2021 H.R. 3460 - State Antitrust Enforcement Venue Act of 2021 S.2428 - False Claims Amendments Act of 2021 S.2429 - Administrative False Claims Act of 2021 H.R.4445 - Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Government Issues
S.2429, Administrative False Claims Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE